Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page's metadata. The change does not alter study details or how the page is presented to users.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page now references Revision: v3.6.2, replacing v3.6.0, indicating a newer version of the study protocol/document is referenced on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment has ended for this study. The page also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision reference to v3.6.0, including an added Intervention/Treatment section.SummaryDifference0.5%

- Check47 days agoChange DetectedRevision tag on the page was updated from v3.5.4 to v3.5.5, indicating a new software release for the site.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page's revision entry was updated from v3.5.3 to v3.5.4, replacing the previous revision tag. This reflects a minor update to the page's revision history rather than changes to core content.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a website release/version change rather than a change to the displayed clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.